MIR3059: A Promising Drug Target and Biomarker for Cancer (G113839519)
MIR3059: A Promising Drug Target and Biomarker for Cancer
MIR3059 (hsa-miR-3059-3p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression patterns have made it an attractive target for researchers to study, and various studies have demonstrated its potential in different fields.
MIR3059 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in gene expression regulation. It is expressed in various tissues and cells of the body and is involved in the regulation of various biological processes, including cell growth , apoptosis, and inflammation.
One of the most significant aspects of MIR3059 is its expression patterns. It is expressed in almost all human tissues and has been shown to be highly expressed in various cancer types, including breast, ovarian, and prostate cancer. This makes it an attractive target for cancer therapies that aim to reduce the expression of MIR3059.
Another important aspect of MIR3059 is its structure. It has a unique structure that is different from other miRNAs. It has a length of 29 amino acid residues and a calculated size of 30 nucleotides. Its structure is composed of a stem-loop region, which is the core of the miRNA, and a terminal region, which contains a tail-like structure.
MIR3059 has also been shown to play a role in various cellular processes. For example, it has been shown to regulate the expression of target genes, including cancer-related genes. , which is the process by which cells die naturally.
In addition to its potential as a drug target, MIR3059 has also been shown to be a potential biomarker for various diseases. For example, it has been shown to be highly expressed in various types of cancer and has been used as a biomarker for cancer diagnosis and prognosis.
One of the most promising aspects of MIR3059 is its potential as a drug target. Research has shown that MIR3059 can interact with various drug molecules and has been shown to have a positive impact on cellular processes that are important for cancer treatment. For example, MIR3059 has been shown to inhibit the activity of the drug PD-L1, which is commonly used in cancer therapies.
In addition to its potential as a drug target, MIR3059 has also been shown to have potential as a biomarker. Its unique structure and expression patterns make it an attractive target for researchers to study, and various studies have demonstrated its potential in different fields. For For example, MIR3059 has been shown to be highly expressed in various types of cancer and has been used as a biomarker for cancer diagnosis and prognosis.
In conclusion, MIR3059 is a non-coding RNA molecule that has shown promise as a potential drug target and biomarker for various diseases. Its unique structure and expression patterns make it an attractive target for researchers to study, and its potential as a drug target and biomarker make it an important molecule to study further. Further research is needed to fully understand the role of MIR3059 in different cellular processes and its potential as a drug and biomarker.
Protein Name: MicroRNA 3059
The "MIR3059 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3059 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5
